Shares of Abbott Laboratories are climbing on Wednesday after the company reported first-quarter net income that fell 31%, but adjusted earnings still managed to beat expectations. Excluding items, Abbott earned $0.41 a share, topping analyst expectations of $0.36 a share, according to Thomson Reuters. Abbott’s results were weighed down by a negative impact of foreign exchange rates as well as the shutdown of a drug manufacturing plant. The company reaffirmed its 2014 earnings forecast.
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
